Retraction: “Small Interfering RNA Effectively Inhibits Protein Expression and Negative Strand RNA Synthesis From a Full-Length Hepatitis C Virus Clone”, (J. Med. Virol, (2005), 76, (511-519), 10.1002/jmv.20391);Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone

Journal of Medical Virology

Volumn 76, Issue 4, 2005, Pages 511-519

  Prabhu, Ramesh ^a   Vittal, Padmaja ^a   Yin, Qinyan ^a   Flemington, Erik ^a   Carry, Robert ^a   Robichaux, William H ^b   Dash, Srikanta ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Thibodaux Regional Medical Center   (United States)

Author keywords

Hepatitis C virus replication; Negative strand HCV RNA; Ribonuclease protection assay; Small interfering RNA; T7 RNA polymerase

Indexed keywords

INTERFERON; RIBAVIRIN; RNA POLYMERASE; SMALL INTERFERING RNA;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE REPLICATION; GENETIC TRANSCRIPTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; MOLECULAR CLONING; PLASMID; PROTEIN EXPRESSION; PROTEIN TARGETING; RIBONUCLEASE PROTECTION ASSAY; RNA INTERFERENCE; RNA SYNTHESIS; WESTERN BLOTTING;

ADENOVIRIDAE; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4;

EID: 21744462419     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.29574     Document Type: Erratum

References (59)

1. Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH. 1995. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22: 707-717.
2. Alter MJ. 1997. Epidemiology of hepatitis C. Hepatology 26:62S-65S.
3. Barton GM, Medzhitov R. 2002. Retroviral delivery of small interfering RNA in to primary cell. Proc Natl Acad Sci USA 99:14943-14945.
4. Blight KJ, Kolykhalov AA, Rice CM. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
5. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz A-L, Iggo R. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34:263-264.
6. Brown EA, Zhang H, Ping LH, Lemon SM. 1992. Secondary structure of the 5′ non-translated regions of hepatitis C virus and pestivirus genomic RNAs. Nucl Acids Res 20:5041-5045.
7. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
8. Bukh J, Purcell RH, Miller RH. 1992. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 89:4942-4946.
9. Chang J, Taylor JM. 2003. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J Virol 77:9728-9731.
10. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DM, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
11. Coburn GA, Cullen BR. 2002. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76:9225-9231.
12. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. 2001. Duplexes of 21-nucleitide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
13. Friebe P, Bartenschlager R. 2002. Genetic analysis of sequences in the 3′ non-translated region of hepatitis C virus that are important for RNA replication. J Virol 76:5326-5338.
14. Friebe P, Lohmann V, Krieger N, Bartenschalager R. 2001. Sequences in the 5′ non-translated region of hepatitis C virus required for RNA replication. J Virol 75:12047-12057.
15. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. 2003. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8:769-776.
16. Gitlin L, Karelsky S, Andino R. 2002. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418:430-434.
17. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385-1395.
18. Hannon GJ. 2002. RNA interference. Nature 418:244-251.
19. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547-5551.
20. Hoofnagle JH, DiBisceglie AM. 1997. The treatment of chronic viral hepatitis. N Engl J Med 336:347-356.
21. Houghton M, Weiner A, Han JH, Kuo G, Choo Q-L. 1991. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
22. Jacque JM, Triques K, Stevenson M. 2002. Modulation of HIV-1 replication by RNA interference. Nature 418:435-438.
23. Jeffers L. 2000. Hepatocellular carcinoma: An emerging problem with hepatitis C. J Natl Med Assoc 92:369-371.
24. Jia Q, Sun R. 2003. Inhibition of gammaherpesvirus replication by RNA interference. J Virol 77:3301-3306.
25. Kapadia SB, Brideau-Andersen A, Chisari FV. 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. PNAS 100:2014-2018.
26. Klein C, Bock CT, Wedemeyer H, Wustefeld T, Locarnini S, Dienes HP, Kubicka S, Manns MP, Traitwein C. 2003. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 125:9-18.
27. Kolykhalov AA, Feinstone S, Rice CM. 1996. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 70:3363-3371.
28. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570-574.
29. Konishi M, Wu CH, Wu GY. 2003. Inhibition of HBV replication by siRNA in a stable HBV-producing cell-line. Hepatology 38:842-850.
30. Lee NS, Dohjima T, Bauer G, Li MJ, Ehsani A, Salvaterra P, Rossi J. 2002. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20:500-505.
31. Leiber A, He CY, Polyack SJ, Gretch DR, Barr D, Kay MA. 1996. Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J Virol 70: 8782-8791.
32. Li H, Li WX, Ding SW. 2002. Induction and suppression of RNA silencing by an animal virus. Science 296:1319-1321.
33. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM. 1994. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J Virol 68:5063-5073.
34. Lindenbach BD, Rice CM. 2002. RNAi targeting an animal virus: News from the front. Mol Cell 9:925-927.
35. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C RNAs in a hepatoma cell-line. Science 285:110-113.
36. Macejak DG, Jensen KL, Jamison SF, Domenico K, Robert EC, Chaudhary N, von Carlowitz I, Bellon L, Tong MJ, Conrad A, Pavco PA, Blatt LM. 2000. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 31: 769-776.
37. Major ME, Feinstone SM. 1997. The molecular virology of hepatitis C. Hepatology 25:1527-1538.
38. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht LK. 1998. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339:1485-1492.
39. Miller RH, Purcell RH. 1990. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 87:2057-2061.
40. Moradpour D, Blum HE. 1999. Current and evolving therapies for hepatitis C. Eur J Gastroenterol Hepatol 11:1192-1202.
41. Myung J, Khalap N, Kalkeri G, Garry R, Dash S. 2001. Inducible model to study negative strand RNA synthesis and assembly of hepatitis C virus from a full-length cDNA clone. J Virol Methods 94:55-67.
42. Oketani M, Asahina Y, Wu CH, Wu GY. 1999. Inhibition of hepatitis C virus-directed gene expression by a DNA ribonuclease. J Hepatol 31:628-634.
43. Philipps KM, Martinez A, Lu J, Heinz BA, Zhao G. 2004. Small interfering RNA molecules as potential anti-human rhinovirus agents: In vitro potency, specificity, and mechanism. Antiviral Res 61:49-55.
44. Prabhu R, Joshi V, Garry RF, Bastian F, Haque S, Regenstein F, Thung SN, Dash S. 2004. Interferon alpha-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone. Exp Mol Pathol 76:242-252.
45. Randall G, Grakoui A, Rice CM. 2003. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. PNAS 100:235-240.
46. Reed KE, Rice CM. 2000. Overview of hepatitis C virus genome structure, polyprotein processing and protein properties. Curr Top Microbiol Immunol 242:55-84.
47. Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. 2003. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Research 96:27-35.
48. Seo MY, Abrignan S, Houghton M, Han JH. 2003. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J Virol 77:810-812.
49. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. 2003. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834-839.
50. Sullivan DE, Mondelli M, deHaard H, Curiel D, Krasnykh V, Mikheeva G, Dash S, Gerber MA. 2002. Construction and characterisation of intracellular single chain human antibody to hepatitis C virus non-structural 3 protein. J Hepatol 37:660-668.
51. Tanaka T, Kato N, Cho MJ, Sugiyama K, Shimotohno K. 1996. Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 70:3307-3312.
52. Wakita T, Wands JR. 1994. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J Biol Chem 269:14205-14210.
53. Welch PJ, Tritz R, Yei S, Leavitt M, Yu M, Barber J. 1996. A potential therapeutic application of hairpin ribozymes: In vitro and in vivo studies of gene therapy. Gene Ther 3:994-1001.
54. Wiebusch L, Truss M, Hagemeier C. 2004. Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol 85:179-184.
55. Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervaia IG, Arya S, Sarangi F, Harris-Brandts M, Beulieu S, Richardson CD. 2003. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicon propagated in human liver cells. PNAS 100:2783-2788.
56. Xia H, Mao Q, Paulon HL, Davidson BL. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20:1006-1010.
57. Yanagi M, Purcell RH, Emerson SU, Bukh J. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected in to the livers of a chimpanzee. Proc Natl Acad Sci USA 94:8738-8743.
58. Yanagi M, Claire MS, Shapiro M, Emerson SU, Purcell RH, Bukh J. 1998. Transcripts of a chimeric clone of hepatitis C virus genotype Ib are infectious in vivo. Virology 244:161-172.
59. Yi M, Lemon SM. 2003. 3′ non-translated RNA signals required for replication of hepatitis C virus RNA. J Virol 77:3557-3568.